Gencaro(TM) Demonstrated 74% Risk Reduction for New Onset Atrial Fibrillation ... MarketWatch (press release) Pursuant to their analysis, researchers concluded that Gencaro substantially decreased the risk of new onset atrial fibrillation in a large moderate-to-severe heart failure population, with a risk reduction of 41%. Furthermore, the researchers ... |
